Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Daito Pharmaceutical Co., Ltd. ( (JP:4577) ) just unveiled an update.
Daito Pharmaceutical Co., Ltd. announced a partial correction to their financial results presentation for the first half of the fiscal year ending May 2025. The corrections were necessary due to inaccuracies discovered post-release, and the updated materials will be available on the company’s website, potentially impacting stakeholders by ensuring accurate financial reporting.
More about Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of medicinal products. The company is listed on the Prime Market of the Tokyo Stock Exchange under the securities code 4577.
YTD Price Performance: -1.24%
Average Trading Volume: 26,498
Technical Sentiment Consensus Rating: Buy
Current Market Cap: Yen31.67B
For a thorough assessment of 4577 stock, go to TipRanks’ Stock Analysis page.
